Similarly, changes in global longitudinal strain did not reach statistical significance in any of the 2 phases (Phase 1: from −12.5 ± 2.4% to −12.8 ± 2.6%, p = 0.77; Phase 2: from −12.8 ± 2.6% to 13.8 ± 2.7%, p = 0.36; Figure 4A ).
← all excerpts
A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction.
1
0.7700
0.7700